Videra Surgical

Videra Surgical is a private, commercial-stage medical device company developing solutions for breast cancer surgery and radiation therapy. Its core technology, the VeraForm tissue marker, provides a continuous, customizable, and permanent 3D target for imaging, which has been integrated with MIM Software's radiation oncology planning platform to enable auto-contouring. Founded in 2016 and based in San Francisco, the company is led by experienced medical device entrepreneurs and is positioned to address a key challenge in breast-conserving therapy by improving the accuracy and efficiency of tumor bed localization for radiation treatment.

VeraForm: an adaptable, radiopaque, non-metallic tissue marker that creates a continuous, permanent 3D outline of a surgical tumor bed for enhanced visibility in X-ray, CT, and mammography, integrated with auto-contouring software (MIM Software) for radiation therapy planning.

Videra primarily competes against standard metallic surgical clips, which are widely used but offer only point-specific, potentially migratable markers. Other potential competitors include other bioabsorbable or radiopaque markers and cavity evaluation devices. VeraForm's key differentiators are its continuous 3D marking capability, lack of MRI artifact, and unique software auto-contouring integration.